Organovo names Norman Staskey President and CFO; Tomas Hess resigns for retirement

VivoSim Labs, INC.

Tomas Hess resigned as President, CFO effective Dec 24, 2024 to pursue retirement; no disagreement on accounting policies.
Norman Staskey appointed President, CFO and Principal Financial Officer effective Dec 30, 2024, via Danforth Advisors consulting agreement.
Staskey is paid $450/hour under the Danforth Consulting Agreement; he also serves as CFO of Azitra, Inc.
Staskey brings M&A experience as company pursues potential strategic transactions with other pharma firms.
Amendment No. 6 to Consulting Agreement formalizes Staskey's services; prior CFO services were from Hess.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.